Paul Fonteyne

Paul Fonteyne has spent 30+ years in the pharmaceutical industry, retiring at the end of 2018 as Chairman of Boehringer-Ingelheim USA, the US arm of Boehringer-Ingelheim, a privately held research-driven pharmaceutical company with a rich and growing portfolio of Human Pharmaceuticals, animal health products, and biologics contract manufacturing. Paul was with Boehringer-Ingelheim for 15 years in leadership roles both in the US and globally. Prior to Boehringer-Ingelheim, Paul had commercial leadership roles at Merch and Co. Inc. and Abbott Laboratories. Paul holds an MS in Chemical Engineering from the University of Brussels and an MBA from Carnegie Mellon University.